Perceptive Imaging, a global leader in clinical trial imaging solutions for the international clinical research community, is pleased to announce the appointment of Doug Fulling as CEO. He succeeds David Herron, who has led the Company since 2022.
Fulling assumed his new position on October 1 and will lead an ambitious growth strategy aimed at significantly improving customer service, developing innovative new technologies, and increasing capacity to help Perceptive’s clients achieve their clinical development goals. Following the transition, Herron will remain with the company and retain his seat on Perceptive Imaging’s board of directors.
Doug Fulling brings more than 25 years of executive management and business development experience in the life sciences industry. This includes serving as President of Precision AQ (part of the Precision Medicine Group) and, prior to that, as President of Symphony Health (an ICON Plc company). Prior to that, he held a number of other leadership positions at leading industry companies such as PRA Health Sciences and MDS Pharma Services.
Thanks to its customer-centric business model, Perceptive Imaging has achieved significant new business growth in recent years and secured a solid pipeline of upcoming studies. Thanks to its position among the top 20 pharmaceutical companies and leading industry players, Perceptive Imaging has continued to successfully secure several mandate renewals from some of the world’s leading pharmaceutical companies. As of June 30, 2025, Perceptive Imaging has supported nearly 400 regulatory approvals.
Also Read: 4BIO Capital founded Trogenix Raises £70M Series A to Advance Cancer Therapies
Doug Fulling commented on his appointment: “Perceptive Imaging has undergone significant transformation in recent years and is well positioned to embark on the next chapter in the company’s development. I have followed the company’s development for more than a decade and am deeply honored to be joining the Perceptive team at such an exciting time. I look forward to working with my new colleagues and our customers to deliver the imaging solutions and services needed to bring new medical treatments to patients more quickly. David Herron is joining the Board, and we thank him for all the work he has done during his tenure as CEO to develop Perceptive Imaging into a state-of-the-art healthcare platform with very exciting future prospects.”
David Herron said, “We are delighted to appoint a leader of Doug Fulling’s caliber to lead Perceptive Imaging into the future. His extensive experience and proven track record of scaling companies with integrity and vision, coupled with the incredible expertise, knowledge, and dedication of all our employees, position Perceptive to realize our ambitious plans. I am incredibly proud of what the team and I have built together over the past few years and am excited about the future. I am confident that Perceptive will continue to grow under Doug’s leadership, and I look forward to supporting him and the team as a member of the Board of Directors as they drive innovation and build new strategic partnerships that ensure long-term success for Perceptive and its customers.”
Source: Businesswire